Catalyst Pharmaceuticals is a biopharmaceutical company that develops and markets drugs for the treatment of neurological and neuromuscular diseases. The company serves customers all across the United States. They employ 76 workers across the globe with a total market cap…
Wally HSO – A Robotic Assistance Device Wally HSO is a standalone RAD solution that allows end users to save significant money while improving performance over the previous generation. Applications from RAD Solutions and Artificial Intelligence Technology Solutions, Inc. can…
Lixte Biotechnology(LIXT) shares increased more than 100% percent in Friday’s premarket session. Lixte holdings is a technology company that focuses on drug discovery and creates drugs that will help patients with cancer. Lixte’s primary product in the pipeline is, according…
Electric automaker Nio (NIO), the Tesla (TSLA) competitor, may be coming to a dealership near you in America. This move would be highly beneficial to Nio and may very well overtake electric vehicle maker Tesla in market share. NIO is…
Shares of Relief Therapeutics (OTC:RLFTF) has gained momentum again as the company affirms Zyesami COVID-19 trial. Together with it’s partner NeuroRx, these companies have breakthrough treatments for the COVID-19 coronavirus. RLFTF Stock: This week could be exciting for Relief Therapeutics…
Shares of Senseonics (SENS), a vital competitor to DexCom (DXCM) has seen it’s shares surge 240% this month. However, there is no news released by the company that would warrant a surge of 16% at the opening bell. Here’s a…
Shares of Relief Therapeutics (OTC:RLFTF) partner NeuroRx (BRPA) has risen 171% this month on anticipated data of it’s progress with COVID-19 candidate Zyesami. NeuroRx announced yesterday that they have begun Zyesami’s Phase 2/3 of the clinical investigation for treatment of…
Shares of Tyme Technologies (TYME) has surged 100% on a new COVID-19 patent that could treat the virus. The company is an emerging biotechnology company that is also developing cancer metabolism-based therapies. The company received a notification that the United…
Shares of Ocugen (OCGN) surged 55% on the execution of their distribution agreement for COVID vaccine COVAXIN by partner Bharat Biotech. The company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to…
Senseonics (SENS) is due to report earnings on February 1, 2021. The company just announced that it has closed their $115MM Bought Deal Offering of common stock with option to purchase additional shares. The Company intends to use the net…
